TY - JOUR AU - Londoño, María-Carlota AU - Riveiro-Barciela, Mar AU - Ahumada, Adriana AU - Muñoz-Gómez, Raquel AU - Roget, Mercé AU - Devesa-Medina, María J AU - Serra, Miguel Ángel AU - Navascués, Carmen A AU - Baliellas, Carme AU - Aldamiz-Echevarría, Teresa AU - Gutiérrez, María L AU - Polo-Lorduy, Benjamín AU - Carmona, Isabel AU - Benlloch, Salvador AU - Bonet, Lucía AU - García-Samaniego, Javier AU - Jiménez-Pérez, Miguel AU - Morán-Sánchez, Senador AU - Castro, Ángeles AU - Delgado, Manuel AU - Gea-Rodríguez, Francisco AU - Martín-Granizo, Ignacio AU - Montes, María Luisa AU - Morano, Luís AU - Castaño, Manuel A AU - de Los Santos, Ignacio AU - Laguno, Montserrat AU - Losa, Juan Emilio AU - Montero-Alonso, Marta AU - Rivero, Antonio AU - de Álvaro, Cristina AU - Manzanares, Amanda AU - Mallolas, Josep AU - Barril, Guillermina AU - González-Parra, Emilio AU - García-Buey, Luisa PY - 2019 DO - 10.1371/journal.pone.0221567 UR - http://hdl.handle.net/10668/14541 T2 - PloS one AB - Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r ± DSV (3D/2D... LA - en KW - 2-Naphthylamine KW - Aged KW - Anilides KW - Antiviral Agents KW - Carbamates KW - Coinfection KW - Cyclopropanes KW - Drug Therapy, Combination KW - Female KW - Genotype KW - HIV Infections KW - HIV-1 KW - Hepacivirus KW - Hepatitis C, Chronic KW - Humans KW - Lactams, Macrocyclic KW - Macrocyclic Compounds KW - Male KW - Middle Aged KW - Proline KW - Renal Dialysis KW - Renal Insufficiency, Chronic KW - Retrospective Studies KW - Ribavirin KW - Ritonavir KW - Spain KW - Sulfonamides KW - Sustained Virologic Response KW - Treatment Outcome KW - Uracil KW - Valine TI - Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study. TY - research article VL - 14 ER -